Written by: Planify
Published: 20 June 2025
Updated: 20 June 2025
1 min read
The Enforcement Directorate (ED) has withdrawn its summons issued to Senior Advocate Arvind Datar regarding the investigation into the Employee Stock Options (ESOPs) granted by Care Health Insurance to Rashmi Saluja, the former chairperson of Religare Enterprises. The ED had initially requested Datar's appearance due to a legal opinion he provided supporting the ESOP grant, which is currently under scrutiny. However, the agency has now communicated that his presence is no longer required.
Reports indicate that Datar argued lawyers cannot be compelled to testify about matters involving the legal advice they give to their clients. He cited professional privilege, asserting that such disclosures are prohibited. This development comes amid the ongoing investigation into the controversial ESOP granted by Care Health Insurance to Dr. Rashmi Saluja, the former chairperson of Religare Enterprises Limited (REL). As the investigation progresses, it intensifies further into the regulatory measures and asset freezes implemented earlier.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
Address
MiQB, Plot 23, Sector 18, Maruti Industrial Development Area, Opposite VLCC corporate office, Gurugram, Haryana 122015
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India